Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit

@inproceedings{Kripke2016HypnoticDR,
  title={Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit},
  author={Daniel F Kripke and Barbara Ann Phillips and Jerome M Siegel},
  booktitle={F1000Research},
  year={2016}
}
This is a review of hypnotic drug risks and benefits, reassessing and updating advice presented to the Commissioner of the Food and Drug Administration (United States FDA). Almost every month, new information appears about the risks of hypnotics (sleeping pills). This review includes new information on the growing USA overdose epidemic, eight new epidemiologic studies of hypnotics' mortality not available for previous compilations, and new emphasis on risks of short-term hypnotic prescription… CONTINUE READING
Tweets
This paper has been referenced on Twitter 22 times. VIEW TWEETS

References

Publications referenced by this paper.
SHOWING 1-10 OF 67 REFERENCES

Beers Criteria Update Expert Panel : American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

  • DF Kripke, S Ancoli-Israel, MR Klauber
  • J Am Geriatr Soc .
  • 2015

Similar Papers

Loading similar papers…